Ctrl/Cmd K

Loading stock analysis…

Explore

Stocks
Screener
IPOs
News

Tools

Backtest
Portfolio
Wealth
ITR

Learn

Guides
Methodology

Company

About
Contact
Disclosures
Privacy
Terms

© 2026 Anvest. All rights reserved.

Designed & Engineered in India·harsh@anvest.in

Disclaimer: Anvest provides financial analytics, screening simulations, and planning tools for informational and educational purposes only. Anvest is not a SEBI-registered investment advisor or broker. Nothing herein constitutes investment advice or an offer to buy/sell securities. Full details on methodology and limitations are documented under Disclosures and Terms.

Stocks›Healthcare

Viyash Scientific Limited

VIYASH · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹218.39

−₹6.16 (−2.74%)(1D)

₹178.1352 Week Range₹298.00

Chart Score AI Profile Fundamentals Technicals Financials Shareholding Peers Filings

Anvest Score

54/100

Valuation

26/100

Quality

66/100

Growth

60/100

Health

69/100

Momentum

49/100

Valuation
26
Quality
66
Growth
60
Health
69
Momentum
49

Loading company profile…

Loading fundamentals…

Loading technical indicators…

Loading financial statement…

Loading shareholding…

Loading peer comparison…

Loading filings…

More Page Context

Research at a glance

Viyash Scientific Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹218.39

Market cap

₹9,541 Cr

P/E ratio

43.42

P/B ratio

3.28

Dividend yield

Not available

ROE

Not available

RSI 14

41.39

1Y return

Not available

Viyash Scientific Limited FAQs

3 topics

ExpandCollapse

Related paths

Peer links appear when comparable names are available.

Open screener Curated screens Backtest ideas

What does the Viyash Scientific Limited (VIYASH) stock page cover?

Viyash Scientific Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for VIYASH?

Viyash Scientific Limited is currently shown with a delayed price near ₹218.39, P/E 43.42.

Does the VIYASH page provide investment advice?

No. The VIYASH page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring

Related insights

PGHL

Procter & Gamble Health Limited · Healthcare

STAR

Strides Pharma Science Limited · Healthcare

AKUMS

Akums Drugs and Pharmaceuticals Limited · Healthcare

How to Backtest Combined Fundamental + Technical Strategies in India

Learn how to backtest hybrid investment strategies combining balance sheet fundamentals with price action and moving averages on NSE stocks.

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Viyash Scientific Limited is an integrated pharmaceutical company formerly known as SeQuent Scientific Limited. It manufactures and sells Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished formulations, also offering CDMO and analytical services.

Drug Manufacturers - Specialty & GenericFounded:1985CEO/MD:Dr. Haribabu Bodepudi

Business at a Glance

The company operates across multiple geographies with manufacturing facilities in India, Turkey, Brazil, Spain, and Germany.
Viyash Scientific serves over 150 countries and has more than 250 global customers.

What Looks Strong

Financial highlights are being recalculated.

What to Watch

Financial highlights are being recalculated.

Reports a single operating segment in its results filings.
The company generates revenue by developing, manufacturing, and selling a portfolio of specialty and generic pharmaceutical products.
This involves research and development, obtaining regulatory approvals, and commercializing drugs to healthcare providers and patients.